Ptc Therapeutics (PTCT) Current Assets (2012 - 2026)

Ptc Therapeutics' Current Assets history runs 15 years deep, the most recent figure standing at $2.3 billion for Q1 2026.

• In Q1 2026, Current Assets fell 2.69% year-over-year to $2.3 billion; the TTM figure through Mar 2026 stood at $2.3 billion (down 2.69% YoY), while the FY2025 annual figure was $2.3 billion, up 66.52% from the prior year.
• Current Assets was $2.3 billion for Q1 2026 at Ptc Therapeutics, down from $2.3 billion in the prior quarter.
• In the past five years, Current Assets ranged from a high of $2.3 billion in Q1 2025 to a low of $517.3 million in Q3 2022.
• Historically, Current Assets has averaged $1.3 billion across 5 years, with a median of $1.2 billion in 2023.
• The sharpest annual moves came in 2022 and 2024: Current Assets sank 48.84% in 2022, then jumped 137.17% in 2024.
• A 5-year view of Current Assets shows it stood at $693.8 million in 2022, then jumped by 75.65% to $1.2 billion in 2023, then climbed by 12.05% to $1.4 billion in 2024, then surged by 66.52% to $2.3 billion in 2025, then declined by 0.88% to $2.3 billion in 2026.
• The last three Current Assets figures came in at $2.3 billion (Q1 2026), $2.3 billion (Q4 2025), and $2.0 billion (Q3 2025), per Business Quant data.